Shopping Cart 0
Cart Subtotal
USD 0

Vitrolife AB (VITR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Vitrolife AB (Vitrolife) is a developer, producer and marketer of laboratory products. The company provides products such as follicle aspiration needles, sperm processing, culture media, culture oil, additional culture media, micromanipulation solutions, vitrolife labware, micromanipulation pipettes, and others. It offers products such as time lapse system, vitrification, slow freezing, octax laser and imaging system, log and guard, fertiproof and embryo biopsy. Vitrolife provides products for the preparation, cultivation, preservation and support of human cells, tissues and organs. The company supplies media and related disposables, which are used by laboratories and hospitals performing fertility treatment and other therapies where cells or tissues are used or are a part of the therapy. It offers optimized solutions for organ, tissue and cell preservation in connection with transplantation. The company operates in Sweden and the US. Vitrolife is headquartered in Gothenburg, Sweden.

Vitrolife AB (VITR)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Vitrolife AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Vitrolife AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Vitrolife AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Vitrolife AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Vitrolife AB, Medical Devices Deals, 2012 to YTD 2018 9

Vitrolife AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Vitrolife AB, Pharmaceuticals & Healthcare, Deal Details 11

Licensing Agreements 11

BioLamina Enters Into Licensing Agreement With Vitrolife For Cryopreservation Medium 11

Equity Offering 12

Vitrolife Completes Private Placement Of Shares For USD 2 Million 12

Acquisition 13

William Demant Invest Acquires Minority Stake in Vitrolife from Bure Equity 13

Vitrolife Acquires 4.6% Stake In Biolamina For USD 0.6 Million 14

PKA Acquires 25% Stake In Unisense FertiliTech For USD 20 Million 15

Vitrolife Completes Acquisition Of Cryo Management For Up To USD 17 Million 16

Vitrolife AB-Key Competitors 17

Vitrolife AB-Key Employees 18

Vitrolife AB-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 21

Financial Announcements 21

Jul 13, 2018: Vitrolife: Interim report January-June 2018 21

Apr 24, 2018: Vitrolife: Interim Report January-March 2018: High Profitability and Time-lapse Growth 22

Feb 08, 2018: Vitrolife: Report on operations 2017: Continued profitable growth 23

Nov 02, 2017: Vitrolife: Interim report January-September 2017: Continuing high growth and profitability 24

Jul 14, 2017: Vitrolife: Interim report January-June 2017: Successes in Asia and in Time-lapse 25

Apr 25, 2017: Vitrolife: Interim report January-March 2017: Good growth in all regions 26

Feb 09, 2017: Vitrolife: Report On Operations 2016: Strong Growth And Strengthened Income 27

Corporate Communications 28

Sep 12, 2018: Vitrolife strengthens organization in business development 28

Appendix 29

Methodology 29

About GlobalData 29

Contact Us 29

Disclaimer 29


List Of Figure

List of Figures

Vitrolife AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Vitrolife AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Vitrolife AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Vitrolife AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Vitrolife AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Vitrolife AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Vitrolife AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Vitrolife AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Vitrolife AB, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Vitrolife AB, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Vitrolife AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Vitrolife AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Vitrolife AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Vitrolife AB, Deals By Therapy Area, 2012 to YTD 2018 8

Vitrolife AB, Medical Devices Deals, 2012 to YTD 2018 9

Vitrolife AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

BioLamina Enters Into Licensing Agreement With Vitrolife For Cryopreservation Medium 11

Vitrolife Completes Private Placement Of Shares For USD 2 Million 12

William Demant Invest Acquires Minority Stake in Vitrolife from Bure Equity 13

Vitrolife Acquires 4.6% Stake In Biolamina For USD 0.6 Million 14

PKA Acquires 25% Stake In Unisense FertiliTech For USD 20 Million 15

Vitrolife Completes Acquisition Of Cryo Management For Up To USD 17 Million 16

Vitrolife AB, Key Competitors 17

Vitrolife AB, Key Employees 18

Vitrolife AB, Subsidiaries 19

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Vitrolife AB, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Vitrolife AB (Vitrolife) is a developer, producer and marketer of laboratory products. The company provides products such as follicle aspiration needles, sperm processing, culture media, culture oil, additional culture media, micromanipulation solutions, vitrolife labware, micromanipulation pipettes, and others. It offers products such as time lapse system, vitrification, slow freezing, octax laser and imaging system, log and guard, fertiproof and embryo biopsy. Vitrolife provides products for the preparation, cultivation, preservation and support of human cells, tissues and organs. The company supplies media and related disposables, which are used by laboratories and hospitals performing fertility treatment and other therapies where cells or tissues are used or are a part of the therapy. It offers optimized solutions for organ, tissue and cell preservation in connection with transplantation. The company operates in Sweden and the US. Vitrolife is headquartered in Gothenburg, Sweden.

Vitrolife AB (VITR)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Vitrolife AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Vitrolife AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Vitrolife AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Vitrolife AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Vitrolife AB, Medical Devices Deals, 2012 to YTD 2018 9

Vitrolife AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Vitrolife AB, Pharmaceuticals & Healthcare, Deal Details 11

Licensing Agreements 11

BioLamina Enters Into Licensing Agreement With Vitrolife For Cryopreservation Medium 11

Equity Offering 12

Vitrolife Completes Private Placement Of Shares For USD 2 Million 12

Acquisition 13

William Demant Invest Acquires Minority Stake in Vitrolife from Bure Equity 13

Vitrolife Acquires 4.6% Stake In Biolamina For USD 0.6 Million 14

PKA Acquires 25% Stake In Unisense FertiliTech For USD 20 Million 15

Vitrolife Completes Acquisition Of Cryo Management For Up To USD 17 Million 16

Vitrolife AB-Key Competitors 17

Vitrolife AB-Key Employees 18

Vitrolife AB-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 21

Financial Announcements 21

Jul 13, 2018: Vitrolife: Interim report January-June 2018 21

Apr 24, 2018: Vitrolife: Interim Report January-March 2018: High Profitability and Time-lapse Growth 22

Feb 08, 2018: Vitrolife: Report on operations 2017: Continued profitable growth 23

Nov 02, 2017: Vitrolife: Interim report January-September 2017: Continuing high growth and profitability 24

Jul 14, 2017: Vitrolife: Interim report January-June 2017: Successes in Asia and in Time-lapse 25

Apr 25, 2017: Vitrolife: Interim report January-March 2017: Good growth in all regions 26

Feb 09, 2017: Vitrolife: Report On Operations 2016: Strong Growth And Strengthened Income 27

Corporate Communications 28

Sep 12, 2018: Vitrolife strengthens organization in business development 28

Appendix 29

Methodology 29

About GlobalData 29

Contact Us 29

Disclaimer 29


List Of Figure

List of Figures

Vitrolife AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Vitrolife AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Vitrolife AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Vitrolife AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Vitrolife AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Vitrolife AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Vitrolife AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Vitrolife AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Vitrolife AB, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Vitrolife AB, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Vitrolife AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Vitrolife AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Vitrolife AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Vitrolife AB, Deals By Therapy Area, 2012 to YTD 2018 8

Vitrolife AB, Medical Devices Deals, 2012 to YTD 2018 9

Vitrolife AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

BioLamina Enters Into Licensing Agreement With Vitrolife For Cryopreservation Medium 11

Vitrolife Completes Private Placement Of Shares For USD 2 Million 12

William Demant Invest Acquires Minority Stake in Vitrolife from Bure Equity 13

Vitrolife Acquires 4.6% Stake In Biolamina For USD 0.6 Million 14

PKA Acquires 25% Stake In Unisense FertiliTech For USD 20 Million 15

Vitrolife Completes Acquisition Of Cryo Management For Up To USD 17 Million 16

Vitrolife AB, Key Competitors 17

Vitrolife AB, Key Employees 18

Vitrolife AB, Subsidiaries 19

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Vitrolife AB, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.